CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Shares	Additional paid-in capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		140,883
Beginning balance at Dec. 31, 2024	$ 377,478	$ 1,187,696	$ 126,999	$ (647)	$ (936,570)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(5,807)
Purchases of common shares under Share Repurchase Plan	(47,400)	$ (47,400)
Issuance of common shares under Equity Incentive Plan (in shares)		2,671
Issuance of common shares for equity awards	355	$ 22,966	(22,611)
Share-based compensation	(3,409)		(3,409)
Unrealized loss on available-for-sale securities, net	(178)			(178)
Net income	23,344				23,344
Ending balance (in shares) at Mar. 31, 2025		137,747
Ending balance at Mar. 31, 2025	$ 350,190	$ 1,163,262	100,979	(825)	(913,226)
Beginning balance (in shares) at Dec. 31, 2025	132,323	132,323
Beginning balance at Dec. 31, 2025	$ 581,331	$ 1,120,035	111,263	(599)	(649,368)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(2,522)
Purchases of common shares under Share Repurchase Plan	$ (36,819)	$ (36,819)
Issuance of common shares under Equity Incentive Plan (in shares)	64	1,713
Issuance of common shares for equity awards	$ 610	$ 14,138	(13,528)
Tax withholding related to net settlement of equity awards (in shares)		(743)
Tax withholding related to net settlement of equity awards	(10,704)	$ (10,704)
Share-based compensation	(866)		(866)
Unrealized loss on available-for-sale securities, net	(281)			(281)
Net income	$ 34,355				34,355
Ending balance (in shares) at Mar. 31, 2026	130,771	130,771
Ending balance at Mar. 31, 2026	$ 567,626	$ 1,086,650	$ 96,869	$ (880)	$ (615,013)